SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-004394
Filing Date
2022-01-21
Accepted
2022-01-21 16:07:36
Documents
1
Period of Report
2022-01-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4049
  Complete submission text file 0001209191-22-004394.txt   5770
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Issuer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 300 WASHINGTON STREET ONE GATEWAY CENTER, SUITE 351 NEWTON MA 02458
Business Address
Paul Bernard H (Reporting) CIK: 0001906043 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33004 | Film No.: 22546014